quiz 5 (#36-71 - BN, CLASS, & FDA-I)

studied byStudied by 29 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 107

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

108 Terms

1

CANDESARTAN (BN)

Atacand, Various

New cards
2

CANDESARTAN (CLASS)

Angiotensin II Receptor Antagonist

New cards
3

CANDESARTAN (FDA-I)

1. Heart failure
2. HTN

New cards
4

CEFDINIR (BN)

Omnicef, Various

New cards
5

CEFDINIR (CLASS)

Third-Generation Cephalosporin

New cards
6

CEFDINIR (FDA-I)

1. Acute otitis media, pharyngitis, tonsillitis
2. Bronchitis, acute secondary bacterial infection
3. Community acquired pneumonia, uncomplicated skin, and/or subcutaneous tissue infectionCOPD, acute exacerbation
4. Streptococcal pharyngitis, group A (alternative agent for mild, nonanaphylactic penicillin allergy)

New cards
7

CEFUROXIME (BN)

Ceftin, Zinacef, Various

New cards
8

CEFUROXIME (CLASS)

Second-Generation Cephalosporin

New cards
9

CEFUROXIME (FDA-I)

1. Acute infective exacerbation of COPD, uncomplicated skin and/or subcutaneous tissue infection, acute bacterial maxillary sinusitis, uncomplicated UTI
2. Acute otitis media
3. Bronchitis, acute, secondary bacterial infection
4. Gonorrhea, uncomplicated
5. Pharyngitis, tonsillitis
6. UTI (alternative agent), acute uncomplicated cystitis, acute simple cystitis
7. Bite wound, prophylaxis, or treatment

New cards
10

CEPHALEXIN (BN)

Keflex, Daxbia, Various

New cards
11

CEPHALEXIN (CLASS)

First-Generation Cephalosporin

New cards
12

CEPHALEXIN (FDA-I)

1. Infection of skin and/or subcutaneous tissue
2. Osteomyelitis
3. Otitis media, respiratory tract infection, UTI
4. Streptococcal pharyngitis
5. Impetigo, ecthyma
6. Cellulitis (nonpurulent), erysipelas

New cards
13

CLINDAMYCIN ORAL (BN)

Cleocin, Various

New cards
14

CLINDAMYCIN ORAL (CLASS)

Lincosamide Antibiotic

New cards
15

CLINDAMYCIN ORAL (FDA-I)

1. Bacterial infectious disease, susceptible infections due to anaerobic organisms, staphylococci, streptococci, pneumococci
2. Infection of skin and/or subcutaneous tissue
3. Infectious disease of abdomen
4. Lower respiratory tract infection
5. Pelvic inflammatory disease
6. Stepticemia
7. Osteomyelitis
8. Diabetic foot infection

New cards
16

DEXLANSOPRAZOLE (BN)

Dexilant

New cards
17

DEXLANSOPRAZOLE (CLASS)

Proton Pump Inhibitor

New cards
18

DEXLANSOPRAZOLE (FDA-I)

1. Erosive esophagitis, treatment
2. Symptomatic gastroesophageal reflux disease

New cards
19

DOXYCYCLINE (BN)

Vibramycin, Doxy 100, Various

New cards
20

DOXYCYCLINE (CLASS)

Tetracycline Antibiotic

New cards
21

DOXYCYCLINE (FDA-I)

1. Acinetobacter infection
2. Acne vulgaris
3. Gonorrhea, uncomplicated
4. Staphylococcal infection of skin
5. Pneumonia, community-acquired, empiric therapy

New cards
22

ERYTHROMYCIN (BN)

Erythrocin, Various

New cards
23

ERYTHROMYCIN (CLASS)

Macrolide Antibiotic

New cards
24

ERYTHROMYCIN (FDA-I)

1. Bacterial infections

New cards
25

ESOMEPRAZOLE (BN)

Nexium, Various

New cards
26

ESOMEPRAZOLE (CLASS)

Proton Pump Inhibitor

New cards
27

ESOMEPRAZOLE (FDA-I)

1. H. pylori GI infection
2. Erosive esophagitis, GERD treatment
3. Erosive esophagitis, heart burn
4. Prevention of NSAID-induced gastopathy
5. Zollinger-Ellison syndrome

New cards
28

FAMOTIDINE (BN)

Pepcid, Various

New cards
29

FAMOTIDINE (CLASS)

Histamine H₂ Antagonist

New cards
30

FAMOTIDINE (FDA-I)

1. Duodenal ulcer, acute
2. Duodenal ulcer, maintenance
3. Gastroesophageal reflux disease (GERD)
4. Gastric ulcer, acute
5. Indigestion, heartburn (OTC)

New cards
31

FELODIPINE (BN)

Plendil, Various

New cards
32

FELODIPINE (CLASS)

Calcium Channel Blocker, Dihydropyridine

New cards
33

FELODIPINE (FDA-I)

1. HTN

New cards
34

FLUTICASONE NASAL (BN)

Flonase, Xhance, Various

New cards
35

FLUTICASONE NASAL (CLASS)

Intranasal Adrenal Glucocorticosteroid

New cards
36

FLUTICASONE NASAL (FDA-I)

1. Allergic nrhinitis
2. Nonallergic rhinitis
3. Nasal polyps

New cards
37

HEPATITIS A VACCINE (BN)

Havrix, Vaqta

New cards
38

HEPATITIS A VACCINE (CLASS)

Vaccine, Inactivated, Viral

New cards
39

HEPATITIS A VACCINE (FDA-I)

1. Hepatitis A prophylaxis

New cards
40

HEPATITIS B VACCINE (BN)

Engerix-B, Recombivax HB

New cards
41

HEPATITIS B VACCINE (CLASS)

Vaccine, Inactivated, Viral

New cards
42

HEPATITIS B VACCINE (FDA-I)

1. Prevention of hepatitis B infection

New cards
43

HUMAN PAPILLOMAVIRUS VACCINE (BN)

Gardasil 9

New cards
44

HUMAN PAPILLOMAVIRUS VACCINE (CLASS)

Vaccine, Inactivated, Viral

New cards
45

HUMAN PAPILLOMAVIRUS VACCINE (FDA-I)

1. Prevention of human papillomavirus infection, cancer and precancerous lesions of the cervix, vulva, vagina, and anus and genital warts

New cards
46

INFLUENZA VIRUS VACCINE (BN)

Afluria, Fluad, Flublok, Fluzone, FluLaval, Fluarix

New cards
47

INFLUENZA VIRUS VACCINE (CLASS)

Vaccine, Inactivated, Viral

New cards
48

INFLUENZA VIRUS VACCINE (FDA-I)

1. Prevention of influenza infection

New cards
49

INSULIN (BN)

Humulin, Various Analogs

New cards
50

INSULIN (CLASS)

Insulin

New cards
51

INSULIN (FDA-I)

1. Diabetes melitus, Type 1 and 2

New cards
52

IRBESARTAN (BN)

Avapro, Various

New cards
53

IRBESARTAN (CLASS)

Angiotensin II Receptor Antagonist

New cards
54

IRBESARTAN (FDA-I)

1. Diabetic nephropathy in patients with diabetes mellitus type 2 and HTN
2. HTN

New cards
55

LANSOPRAZOLE (BN)

Prevacid, Various

New cards
56

LANSOPRAZOLE (CLASS)

Proton Pump Inhibitor

New cards
57

LANSOPRAZOLE (FDA-I)

1. Duodenal ulcer disease
2. Gasteric ucler disease, treatment
3.
H. pylori GI tract infection, triple therapy
4. Erosive esophagitis, GERD, treatment
5. Zollinger-Ellison syndrome

New cards
58

LINAGLIPTIN (BN)

Tradjenta

New cards
59

LINAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor

New cards
60

LINAGLIPTIN (FDA-I)

1. Diabetes mellitus type 2

New cards
61

METFORMIN (BN)

Glucophage, Various

New cards
62

METFORMIN (CLASS)

Biguanide, Hypoglycemic

New cards
63

METFORMIN (FDA-I)

1. Diabetes mellitus type 2
2. Polycystic ovary syndrome

New cards
64

METRONIDAZOLE (BN)

Flagyl, Various

New cards
65

METRONIDAZOLE (CLASS)

Nitroimidazole Antibiotic, Antiprotozoal

New cards
66

METRONIDAZOLE (FDA-I)

1. Abscess, anaerobic
2. Amebic dysentery, acute Bacterial vaginosis
3. Trichomoniasis (for patient and sex partner)

New cards
67

MINOCYCLINE (BN)

Minocin, Various

New cards
68

MINOCYCLINE (CLASS)

Tetracycline Antibiotic

New cards
69

MINOCYCLINE (CLASS)

1. Acne vulgaris
2. Allergy to penicillin-bacterial infectious disease

New cards
70

MOMETASONE NASAL (BN)

Nasonex, Various

New cards
71

MOMETASONE NASAL (CLASS)

Intranasal Corticosteroid

New cards
72

MOMETASONE NASAL (FDA-I)

1. Seasonal and perennial allergic rhinitis
2. Nasal polyp

New cards
73

NIFEDIPINE (BN)

Adalat CC, Procardia XL, Various

New cards
74

NIFEDIPINE (CLASS)

Dihydropyridine Calcium Channel Blocker

New cards
75

NIFEDIPINE (FDA-I)

1. HTN
2. Stable chronic angina
3. Variant angina

New cards
76

OLMESARTAN (BN)

Benicar, Various

New cards
77

OLMESARTAN (CLASS)

Angiotensin II Receptor Antagonist

New cards
78

OLMESARTAN (FDA-I)

1. HTN

New cards
79

PRAVASTATIN (BN)

Pravachol, Various

New cards
80

PRAVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

New cards
81

PRAVASTATIN (FDA-I)

1. Cerebrovascular accident (prevention), coronary arteriosclerosis (primary or secondary prevention)
2. Familial hypercholesterolemia
3. Hyperlipidemia

New cards
82

QUINAPRIL (BN)

Accupril, Various

New cards
83

QUINAPRIL (CLASS)

ACE-I, Antihypertensive

New cards
84

QUINAPRIL (FDA-I)

1. Heart failure
2. HTN

New cards
85

RAMIPRIL (BN)

Altace, Various

New cards
86

RAMIPRIL (CLASS)

ACE-I, Antihypertensive

New cards
87

RAMIPRIL (FDA-I)

1. Heart failure
2. HTN
3. Reduce risk of myocardial infarction, stroke, and death from cardiovascular causes

New cards
88

ROSUVASTATIN (BN)

Crestor, Ezallor, Various

New cards
89

ROSUVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

New cards
90

ROSUVASTATIN (FDA-I)

1. Hyperlipidemia
2. Disorder of cardiovascular system, primary prophylaxis, familial hypercholesterolemia, homozygous, hypertriglyceridemia, mixed with dsylipidemia

New cards
91

SAXAGLIPTIN (BN)

Onglyza

New cards
92

SAXAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor, Antidiabetic

New cards
93

SAXAGLIPTIN (FDA-I)

1. Diabetes mellitus

New cards
94

SIMVASTATIN (BN)

Zocor, Various

New cards
95

SIMVASTATIN (CLASS)

HMG-CoA Reductase Inhibitor

New cards
96

SIMVASTATIN (FDA-I)

1. Hyperlipidemia
2. Primary and secodary preventions of atherosclerotic cardiovascular disease
3. Secondary prevention of cardiovascular events
4. Familial hypercholesterolemia (homozygous)

New cards
97

SITAGLIPTIN (BN)

Januvia

New cards
98

SITAGLIPTIN (CLASS)

Dipeptidyl Peptidase IV Inhibitor, Antidiabetic

New cards
99

SITAGLIPTIN (FDA-I)

1. Diabetes mellitus, type 2

New cards
100

TETANUS TOXOID (BN)

Daptacel, Adacel, Boostrix, Infanrix

New cards
robot